STRS Ohio’s AstraZeneca AZN Stock Holding History

STRS Ohio’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-182,500	Closed	-$26.8M	–	2207
2025 Q1	$26.8M	Hold	182,500	–	–	0.11%	210
2024 Q4	$23.9M	Hold	182,500	–	–	0.09%	244
2024 Q3	$28.4M	Sell	182,500 -67,500	-27%	-$10.9M	0.11%	208
2024 Q2	$39M	Hold	250,000	–	–	0.15%	149
2024 Q1	$33.9M	Buy	250,000 +35,000	+16%	+$4.63M	0.14%	182
2023 Q4	$29M	Hold	215,000	–	–	0.12%	198
2023 Q3	$29.1M	Sell	215,000 -25,000	-10%	-$3.41M	0.13%	193
2023 Q2	$34.4M	Sell	240,000 -5,000	-2%	-$736K	0.15%	176
2023 Q1	$34M	Buy	245,000 +72,500	+42%	+$9.75M	0.15%	179
2022 Q4	$23.4M	Buy	+172,500	New	+$21.6M	0.11%	243
2013 Q3	–	Sell	-114,699	Closed	-$5.42M	–	1829
2013 Q2	$5.42M	Buy	+114,699	New	+$5.84M	0.02%	486

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

STRS Ohio's AZN Position: Q2 2025 in Review

STRS Ohio sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 182,500 shares — an estimated $26.8M sold.

STRS Ohio first reported a position in AZN in Q2 2013 and held it in 11 quarters. The position peaked at $39M in Q2 2024. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

STRS Ohio reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
STRS Ohio sold 182,500 AstraZeneca shares in Q2 2025, an estimated $26.8M.
STRS Ohio first reported a position in AstraZeneca in Q2 2013 and held it in 11 quarters.
STRS Ohio's AstraZeneca position peaked at $39M in Q2 2024.
1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.